Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c)(@DrBeaMD) 's Twitter Profileg
Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c)

@DrBeaMD

Breast Surgical Oncologist, National Speaker, Educator, Researcher in Breast Cancer Disparities, Children's Book Author, GLOSS Co-Founder. Opinions are my own!

ID:35582038

linkhttp://www.drvivianbea.com calendar_today26-04-2009 22:18:46

1,7K Tweets

1,3K Followers

1,1K Following

Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c)(@DrBeaMD) 's Twitter Profile Photo

Balancing the pursual of an Executive MBA with work/personal life has been challenging but the daily reminders of its reward make it worthwhile. Currently, I am learning about managerial finance and its role in achieving business success πŸ™ŒπŸΎ. Cornell Johnson

Balancing the pursual of an Executive MBA with work/personal life has been challenging but the daily reminders of its reward make it worthwhile. Currently, I am learning about managerial finance and its role in achieving business success πŸ™ŒπŸΎ. #EMBA #MastersinLeadership @CornellMBA
account_circle
Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c)(@DrBeaMD) 's Twitter Profile Photo

The ancestors certainly looked out for me when they matched me with this phenomenal group MD Anderson Cancer Center will always be my family! Great time with my colleagues, mentors and friends

account_circle
Vivian J. Bea, MD, MBS, FACS, eMBA/MS (c)(@DrBeaMD) 's Twitter Profile Photo

For neoadjuvant endocrine therapy we first turn to the ACOSOG-Z1031 trial. NAET can inform decisions on adjuvant chemotherapy in synergy with genomic testing!

For neoadjuvant endocrine therapy we first turn to the ACOSOG-Z1031 trial. NAET can inform decisions on adjuvant chemotherapy in synergy with genomic testing! #Asbrs24
account_circle
ASBrS(@ASBrS) 's Twitter Profile Photo

Genetics: Should we use panel tests?

Benefits: detect more pathogenic mutations

Risks: detect VUS

VUS identification does not lead to more prophylactic mastectomies

Talk with patients about whether to test & how to use results.β€”Dr. Plichta

Genetics: Should we use panel tests? Benefits: detect more pathogenic mutations Risks: detect VUS VUS identification does not lead to more prophylactic mastectomies Talk with patients about whether to test & how to use results.β€”Dr. Plichta #asbrs24
account_circle